Endocrine Abstracts

Previous issue | Volume 73 | ECE2021 | Next issue

European Congress of Endocrinology 2021

Online
22 May 2021 - 26 May 2021

The European Congress of Endocrinology provides a global platform for the international endocrine community to discuss the latest advances in the field.

Oral Communications

Oral Communications 8: Pituitary and Neuroendocrinology

Previous section
Oral Communications 7: Diabetes, Obesity, Metabolism and Nutrition

Table of contents

Next section
Oral Communications 9: Endocrine-Related Cancer

ea0073oc8.1 | Oral Communications 8: Pituitary and Neuroendocrinology

Expression and putative role of 14–3-3 proteins in corticotroph tumours

ea0073oc8.2 | Oral Communications 8: Pituitary and Neuroendocrinology

Osilodrostat is an effective and well-tolerated treatment option for patients with Cushing’s disease (CD): Final results from the LINC3 study

ea0073oc8.3 | Oral Communications 8: Pituitary and Neuroendocrinology

GFRα2 as a GPS marker: Role of GFRα2 in pituitary gland

ea0073oc8.4 | Oral Communications 8: Pituitary and Neuroendocrinology

Novel insight into ACTH-secreting pituitary tumors biological behavior: hormone secretion and cell proliferation modulation by Ubiquitin Specific Peptidase 8 inhibitor RA-9

ea0073oc8.5 | Oral Communications 8: Pituitary and Neuroendocrinology

The clinical effects of miR-26a, miR-16, let-7, miR-128a and miR-223 in acromegaly patients

ea0073oc8.6 | Oral Communications 8: Pituitary and Neuroendocrinology

Increased PCSK1N in silent corticotroph pituitary adenomas may explain their “silence”

Endocrine Abstracts
ISSN 1470-3947 (print) | ISSN 1479-6848 (online)
© Bioscientifica 2025 | Privacy policy | Cookie settings

Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.

Find out more

European Congress of Endocrinology 2021

Oral Communications 8: Pituitary and Neuroendocrinology

BiosciAbstracts